Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511249393

Publication Date:

November 18, 2024

Pages:

118

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) was estimated to be worth US$ 10570 million in 2023 and is forecast to a readjusted size of US$ 14700 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) by region & country, by Type, and by Application.
The Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM).
麻豆原创 Segmentation
By Company
Abbott Laboratories
Dexcom
GlySens Incorporated
Insulet Corp
Johnson & Johnson
Medtronic
Meiqi Medical Equipment
Microport
Roche
Senseonics Holdings
SOOIL
Tandem Diabetes care
Segment by Type:
Insulin Pump
Continuous Glucose Monitors (CGM)
Segment by Application
Child
Adult
Elderly
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Introduction
1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Size Forecast
1.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value (2019-2030)
1.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume (2019-2030)
1.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Price (2019-2030)
1.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Trends & Drivers
1.3.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industry Trends
1.3.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Drivers & Opportunity
1.3.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Challenges
1.3.4 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Players Revenue Ranking (2023)
2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue by Company (2019-2024)
2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Players Sales Volume Ranking (2023)
2.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Company Players (2019-2024)
2.5 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Average Price by Company (2019-2024)
2.6 Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM)
2.9 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Competitive Analysis
2.9.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Insulin Pump
3.1.2 Continuous Glucose Monitors (CGM)
3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type
3.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, by Type (2019-2030)
3.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, by Type (%) (2019-2030)
3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Type
3.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume, by Type (2019-2030)
3.3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume, by Type (%) (2019-2030)
3.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Child
4.1.2 Adult
4.1.3 Elderly
4.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application
4.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, by Application (2019-2030)
4.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, by Application (%) (2019-2030)
4.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Application
4.3.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume, by Application (2019-2030)
4.3.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume, by Application (%) (2019-2030)
4.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Region
5.1.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Region (2019-2024)
5.1.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Region (2025-2030)
5.1.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Region (%), (2019-2030)
5.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Region
5.2.1 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Region (2019-2024)
5.2.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Region (2025-2030)
5.2.4 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume by Region (%), (2019-2030)
5.3 Global Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
5.4.2 North America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
5.5.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
5.6.2 Asia Pacific Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
5.7.2 South America Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
5.8.2 Middle East & Africa Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value
6.2.1 Key Countries/Regions Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.3.2 United States Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.4.2 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.5.2 China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.6.2 Japan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.7.2 South Korea Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.8.2 Southeast Asia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value, 2019-2030
6.9.2 India Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Information
7.1.2 Abbott Laboratories Introduction and Business Overview
7.1.3 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Laboratories Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.1.5 Abbott Laboratories Recent Development
7.2 Dexcom
7.2.1 Dexcom Company Information
7.2.2 Dexcom Introduction and Business Overview
7.2.3 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Dexcom Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.2.5 Dexcom Recent Development
7.3 GlySens Incorporated
7.3.1 GlySens Incorporated Company Information
7.3.2 GlySens Incorporated Introduction and Business Overview
7.3.3 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 GlySens Incorporated Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.3.5 GlySens Incorporated Recent Development
7.4 Insulet Corp
7.4.1 Insulet Corp Company Information
7.4.2 Insulet Corp Introduction and Business Overview
7.4.3 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Insulet Corp Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.4.5 Insulet Corp Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Introduction and Business Overview
7.5.3 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Johnson & Johnson Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.5.5 Johnson & Johnson Recent Development
7.6 Medtronic
7.6.1 Medtronic Company Information
7.6.2 Medtronic Introduction and Business Overview
7.6.3 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Medtronic Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.6.5 Medtronic Recent Development
7.7 Meiqi Medical Equipment
7.7.1 Meiqi Medical Equipment Company Information
7.7.2 Meiqi Medical Equipment Introduction and Business Overview
7.7.3 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Meiqi Medical Equipment Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.7.5 Meiqi Medical Equipment Recent Development
7.8 Microport
7.8.1 Microport Company Information
7.8.2 Microport Introduction and Business Overview
7.8.3 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Microport Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.8.5 Microport Recent Development
7.9 Roche
7.9.1 Roche Company Information
7.9.2 Roche Introduction and Business Overview
7.9.3 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Roche Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.9.5 Roche Recent Development
7.10 Senseonics Holdings
7.10.1 Senseonics Holdings Company Information
7.10.2 Senseonics Holdings Introduction and Business Overview
7.10.3 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Senseonics Holdings Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.10.5 Senseonics Holdings Recent Development
7.11 SOOIL
7.11.1 SOOIL Company Information
7.11.2 SOOIL Introduction and Business Overview
7.11.3 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SOOIL Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.11.5 SOOIL Recent Development
7.12 Tandem Diabetes care
7.12.1 Tandem Diabetes care Company Information
7.12.2 Tandem Diabetes care Introduction and Business Overview
7.12.3 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Tandem Diabetes care Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Product Offerings
7.12.5 Tandem Diabetes care Recent Development
8 Industry Chain Analysis
8.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Industrial Chain
8.2 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Sales Model
8.5.2 Sales Channel
8.5.3 Diabetes Management Insulin Pump and Continuous Glucose Monitors (CGM) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Dexcom
GlySens Incorporated
Insulet Corp
Johnson & Johnson
Medtronic
Meiqi Medical Equipment
Microport
Roche
Senseonics Holdings
SOOIL
Tandem Diabetes care

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.